Although CB1R agonism has been shown to have beneficial effects in animal models of hypertension and heart failure [96,520,523], CB1R antagonism was shown to improve cardiac function after experimental myocardial infarction and metabolic syndrome [544]. Here, CNR1 is linked to myocardial infarction.